ubmslateCN-logo-ubm

CN Mobile Logo

Topics:

Oncology and Hematology News and Journal Articles

2015 ASCO Annual Meeting

Cancer Network presents exclusive coverage from the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting. We’ll bring you reports and interviews of the latest research, trials, scientific advances, and controversies that are changing the way cancer is managed and treated.

Recent Content

Use of a VD regimen alone to treat patients with transplant-ineligible multiple myeloma was not inferior to VTD or VMP regimens, according to the UPFRONT trial.

Large proportions of lung and colorectal cancer patients believe that surgery will cure their cancer, according to results of a new population-based study.

A new study has found that in patients diagnosed with metastatic colorectal cancer, a low BMI could be a poor prognostic factor.

Adding the oral NK1 antagonist aprepitant to an oxaliplatin-based chemotherapy regimen effectively reduced nausea and vomiting in colorectal cancer patients.

Ahead of the ESMO World Congress on Gastrointestinal Cancer, we are discussing the use of maintenance therapy in metastatic colorectal cancer with Axel Grothey, MD.

The FDA has granted a priority review for MM-398 as a second-line treatment for metastatic pancreatic cancer after the drug demonstrated improved survival.

Frequent consumers of citrus fruits were found to have an elevated risk of malignant melanoma.

By clicking Accept, you agree to become a member of the UBM Medica Community.